# Y-90 SIRT for Unresectable HCC Larger Than 7cm

> **NCT06707233** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 33 (estimated)

## Conditions studied

- Hepatocellular Carcinoma Non-Resectable

## Interventions

- **PROCEDURE:** SIRT

## Key facts

- **NCT ID:** NCT06707233
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06707233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06707233, "Y-90 SIRT for Unresectable HCC Larger Than 7cm". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06707233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*